Stocks Comparison
P3 Health Partners vs GeneDx: revenue, profit, margins and growth compared
P3 Health Partners brought in $1.5B of revenue in fiscal 2024, GeneDx $427.5M in fiscal 2025. Revenue changed by -2.8% at P3 Health Partners and +40.0% at GeneDx on the year before, so GeneDx grew faster. P3 Health Partners kept -10.1% of its revenue as net profit, GeneDx -4.9%.
Side by side, latest fiscal year
| PIII | WGS | |
|---|---|---|
| Fiscal year ended | FY2024 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $1.5B | $427.5M |
| Revenue growth | -2.8% | +40.0% |
| Net income | -$147.9M | -$21M |
| Net margin | -10.1% | -4.9% |
| Free cash flow | n/a | $14.3M |
| Free cash flow margin | n/a | 3.3% |
| Earnings per share (diluted) | -$45.26 | -$0.73 |
| Cash | $25M | $105M |
| Debt | $273.4M | $54.5M |
| Price to earnings | n/a | n/a |
| Market value | $51.2M | $2.6B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #124 of 523 · Health care | #199 of 523 · Health care |
Over the years
Questions about P3 Health Partners and GeneDx
Which is bigger by revenue, P3 Health Partners or GeneDx?
P3 Health Partners is bigger by revenue: $1.5B in fiscal 2024, against $427.5M for GeneDx in fiscal 2025.
Which keeps more of its revenue as profit, P3 Health Partners or GeneDx?
P3 Health Partners had a net margin of -10.1% in fiscal 2024; GeneDx had -4.9% in fiscal 2025.
Which grew revenue faster, P3 Health Partners or GeneDx?
In their latest fiscal years revenue changed by -2.8% at P3 Health Partners and +40.0% at GeneDx.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.